HYALURONICA® 3
ADVANCED BIPHASIC TECHNOLOGY. ENGINEERED FOR FLOW, PROJECTION & LONGEVITY.
HYALURONICA® 3 is an advanced biphasic hyaluronic acid filler, designed in France and manufactured in Germany for Aesthetic Services.
Engineered around a distinctive particle-based architecture, HYALURONICA® 3 combines cross-linked hyaluronic acid particles with a non-cross-linked hyaluronic acid gel phase, creating a unique filler designed to deliver an exceptional balance of thixotropy, injectability, projection, tissue integration, and durability.
A UNIQUE BIPHASIC ARCHITECTURE
Unlike conventional homogeneous gels, HYALURONICA® 3 is built around a distinctive biphasic structure.
The cross-linked hyaluronic acid is organized into highly rounded, elastic particles — visually reminiscent of caviar-like microbeads — surrounded and suspended within a continuous phase of non-cross-linked hyaluronic acid.
This architecture is designed to create a highly dynamic gel system in which the two phases work together:
Cross-linked HA particles provide structural integrity, volume, and resistance to enzymatic degradation.
Non-cross-linked HA gel surrounds the particles, acting as a highly fluid carrier phase that facilitates smooth movement and distribution.
The result is a filler with a distinctive combination of structure at rest and flow under pressure.
ENGINEERED FOR HIGH THIXOTROPY
One of the defining characteristics of HYALURONICA® 3 is its high thixotropic behavior.
The filler is designed to respond dynamically to mechanical stress.
At rest, the particle-based structure provides stability and volume.
When pressure is applied through the syringe plunger, the internal structure responds to the applied force, allowing the gel to become significantly more flowable and pass smoothly through the needle.
This creates an important clinical advantage:
High stability when placed — exceptional flowability when injected.
The result is rapid and controlled delivery with excellent spreadability after placement.
POWERFUL FLOW. CONTROLLED DISTRIBUTION.
The specially engineered biphasic structure allows HYALURONICA® 3 to move efficiently under injection pressure.
As pressure is applied, the gel system becomes highly flowable, allowing the product to pass through the needle with remarkable ease and then distribute smoothly within the target tissue.
This combination of high initial flowability and excellent post-injection spreadability helps practitioners achieve controlled placement and efficient tissue distribution.
PARTICLE ARCHITECTURE FOR ENHANCED DURABILITY
The rounded structure of the cross-linked HA particles is designed to reduce the effective exposed surface area of the stabilized HA network.
This architecture may reduce the accessibility of hyaluronidase to the cross-linked HA structure compared with less organized configurations, contributing to greater resistance to enzymatic degradation.
The result is a filler engineered for prolonged persistence within the tissue, while maintaining the fundamental biodegradability expected from hyaluronic acid-based products.
CONTROLLED & HOMOGENEOUS DEGRADATION
The particle-based architecture also provides an interesting approach to the way the filler undergoes enzymatic degradation.
Rather than relying solely on a large continuous cross-linked gel mass, the cross-linked HA is distributed into individual rounded particles.
As degradation occurs, the particles can undergo progressive enzymatic breakdown throughout the implant, supporting a more controlled and progressive reduction of the filler structure.
This is an important distinction from degradation patterns that may be less spatially uniform in some conventional filler architectures.
LONGEVITY WITHOUT COMPROMISING SAFETY
HYALURONICA® 3 is designed around the principle that longevity should come from intelligent material engineering — not simply from increasing cross-linking density.
Its biphasic architecture combines:
Cross-linked HA particles
for structural stability and prolonged persistence.
Non-cross-linked HA phase
for smooth flow, lubrication, and tissue distribution.
Rounded particle geometry
for optimized interaction with the surrounding tissue and reduced enzymatic accessibility.
Together, these features create a sophisticated balance between durability, flowability, controllability, and tissue compatibility.
IDEAL FOR STRUCTURAL & VOLUMIZING APPLICATIONS
HYALURONICA® 3 is designed for deeper tissue applications where volume, projection, structural support, and long-lasting correction are required.
Potential treatment areas include:
- Cheek and midface volumization
- Malar and zygomatic enhancement
- Chin projection and definition
- Jawline contouring
- Facial contour refinement
- Deep facial folds and volume deficiencies
- Structural facial correction
- Correction of selected post-traumatic or contour defects
Its robust yet highly flowable profile makes it particularly suitable for practitioners seeking strong volumizing capacity with smooth product handling and efficient tissue distribution.
THE THIXOTROPY ADVANTAGE
HYALURONICA® 3 is engineered around a simple but powerful concept:
Firm when it needs to be.
Fluid when it needs to flow.
Its high-thixotropy behavior allows the product to transition from a more structured state to a highly flowable state under injection pressure, facilitating delivery through the needle and allowing the filler to spread efficiently after placement.
This creates an advanced balance between injectability and structural performance.
KEY FEATURES
Biphasic HA Technology
Cross-linked HA particles suspended within a non-cross-linked HA gel phase.
High Thixotropy
A dynamic response to mechanical stress designed to provide excellent flow under injection pressure.
Exceptional Injectability
Highly flowable under plunger pressure for smooth and controlled delivery.
Excellent Spreadability
Designed to distribute smoothly within the target tissue after injection.
Particle-Based Architecture
Rounded cross-linked HA particles engineered for structural stability and reduced enzymatic accessibility.
Enhanced Persistence
The cross-linked particle architecture is designed to provide increased resistance to enzymatic degradation and prolonged tissue residence.
Controlled Degradation
A particle-based structure designed to support progressive and more homogeneous enzymatic breakdown.
High Volumizing Capacity
Designed for deeper applications requiring projection, contouring, and structural support.
FRENCH DESIGN. GERMAN MANUFACTURING. ADVANCED BIPHASIC SCIENCE.
HYALURONICA® 3 represents a different approach to dermal filler technology — one that combines particle engineering, rheology, thixotropy, and tissue behavior into a single sophisticated platform.
From the moment pressure is applied to the syringe to the moment the gel settles into the tissue, every aspect of its architecture is designed around one objective:
Maximum control. Smooth integration. Long-lasting performance.
HYALURONICA® 3 — Engineered to Flow. Designed to Last.